...for $15.6 billion, and served as an EVP at AZ after the acquisition. Mott founded MedImmune Ventures...

...Cowen Private Investments; Franklin Templeton; Rock Springs Capital; Eshelman Ventures; Hatteras Venture Partners; Lumira Capital; MedImmune Ventures...

...Springs Capital also participated, as did existing investors Eshelman Ventures, Hatteras Venture Partners, Lumira Capital, MedImmune Ventures...

...less than $22 million since its founding in 2005. Its investors included Health Care Ventures; MedImmune Ventures...

...million Investors: Eshelman Ventures; RA Capital Management; Lumira Capital; Tavistock Life Sciences; Hatteras Venture Partners; MedImmune Ventures...

...and Tavistock Life Sciences' Boxer Capital also participated, as did existing investors Hatteras Venture Partners; MedImmune Ventures...

...The company raised $12.5 million in October 2013 in a series A round led by MedImmune Ventures...

...formerly VP of corporate development and ventures at AstraZeneca plc and chair of the pharma's MedImmune Ventures...

...11/15/13 Type: Venture financing Raised: $32.4 million Investors: Lightstone Ventures; SV Life Sciences; Clarus Ventures; MedImmune Ventures...

...crossover fund also joined all current investors in the round: SV Life Sciences, Clarus Ventures, MedImmune Ventures...